New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- A case of small in situ perihilar cholangiocarcinoma incidentally accompanied by
- 1
- 4 years, 8 months ago
- Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurr
- 1
- 4 years, 8 months ago
- Screening of Molecular Targets of Action of Atractylodin in Cholangiocarcinoma b
- 1
- 4 years, 8 months ago
- Identification of key genes and pathways associated with cholangiocarcinoma deve
- 1
- 4 years, 8 months ago
- Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control stu
- 1
- 4 years, 8 months ago
- iNOS is associated with tumorigenicity as an independent prognosticator in human
- 1
- 4 years, 8 months ago
- New treatment approaches induce responses in unresectable intrahepatic cholangio
- 1
- 4 years, 8 months ago
- MiR-186 suppresses the progression of cholangiocarcinoma cells through inhibitio
- 1
- 4 years, 8 months ago
- Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary
- 1
- 4 years, 8 months ago
- Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2
- 1
- 4 years, 8 months ago
- Intensity Therapeutics Treats First Patient with Combination of INT230-6 and Mer
- 1
- 4 years, 8 months ago
- Moving the Needle Forward With Locoregional Treatment in Unresectable Cholangioc
- 1
- 4 years, 8 months ago
- A comparison of the proportion of early stage cholangiocarcinoma found in an ult
- 1
- 4 years, 8 months ago
- The forum ‘New Developments’ is closed to new topics and replies.